Results

Total Results: 3,981 records

Showing results for "cardiovascular".
Users also searched for: statin

  1. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007_MaskedStats_IP.PDF
    January 01, 2007 - 0.02 106: CORONARY BYPASS W PTCA 731 0.02 108: OTHER CARDIOTHORACIC PROCEDURES 678 0.02 110: MAJOR CARDIOVASCULAR … PROCEDURES W CC 5,555 0.17 111: MAJOR CARDIOVASCULAR PROCEDURES W/O CC 458 0.01 113: AMPUTATION FOR … CV DX 4,868 0.15 554: OTHER VASCULAR PROCEDURES W CC W/O MAJOR CV DX 5,414 0.17 555: PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT W MAJOR CV DX 16,625 0.52 558: PERCUTANEOUS CARDIOVASCULAR PROC W DRUG-ELUTING … procedures 3,011 0.07 63: Other non-OR therapeutic cardiovascular procedures 11,468 0.27 64: Bone
  2. www.uspreventiveservicestaskforce.org/home/getfilebytoken/Jz4WcZ2Wy3-nV6jNUrwUzX
    June 20, 2017 - Refer to USPSTF Procedure Manual for further details.10 BMI indicates bodymass index; CV, cardiovascularCardiovascular disease risk in healthy children and its association with bodymass index: systematic … Insulin resistance and cardiovascular risk factors in 3- to 5-year-old overweight or obese children … Prevalence of cardiovascular disease risk factors among US adolescents, 1999-2008. … Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention
  3. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2009_MaskedStats_Core_Weighted.PDF
    January 01, 2009 - PROCEDURES W CC 5,202 0.07% 111: MAJOR CARDIOVASCULAR PROCEDURES W/O CC 1,616 0.02% 113: AMPUTATION … Percent of Total 554: OTHER VASCULAR PROCEDURES W CC W/O MAJOR CV DX 1,048 0.01% 555: PERCUTANEOUS CARDIOVASCULAR … 556: PERCUTANEOUS CARDIOVASC PROC W NON-DRUG-ELUTING STENT W/O MAJ CV DX 61 0.00% 557: PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT W MAJOR CV DX <= 50 *.**% 558: PERCUTANEOUS CARDIOVASCULAR PROC W DRUG-ELUTING … procedures 814 0.01% 63: Other non-OR therapeutic cardiovascular procedures 1,488 0.02% 64: Bone marrow
  4. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007v2_MaskedStats_IP.PDF
    April 09, 2010 - 0.02 106: CORONARY BYPASS W PTCA 710 0.02 108: OTHER CARDIOTHORACIC PROCEDURES 659 0.02 110: MAJOR CARDIOVASCULAR … PROCEDURES W CC 5,575 0.18 111: MAJOR CARDIOVASCULAR PROCEDURES W/O CC 462 0.01 113: AMPUTATION FOR … CV DX 4,899 0.16 554: OTHER VASCULAR PROCEDURES W CC W/O MAJOR CV DX 5,388 0.17 555: PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT W MAJOR CV DX 16,412 0.53 558: PERCUTANEOUS CARDIOVASCULAR PROC W DRUG-ELUTING … procedures 3,105 0.07 63: Other non-OR therapeutic cardiovascular procedures 11,123 0.27 64: Bone
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-disposition-120516.pdf
    October 01, 2011 - company dedicated to the research and development of new medicines in therapeutic areas including cardiovascular … , starting line 41) states “many trials, but almost exclusively in patients receiving aspirin for cardiovascular … and bone fractures (8) - Increased incidence of infectious processes (9) - Increased incidence of cardiovascular … diseases, effect that may potentiate the cardiovascular ADEs of NSAIDs. … Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel
  6. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2024-11/uspstf-annual-report-congress-2024.pdf
    January 01, 2024 - start screening due in part to the increased incidence in younger age groups • Aspirin use to prevent cardiovascular … Counseling to Promote Healthy Lifestyle and/or Weight Loss in Adults Enhanced Risk Assessment for Cardiovascular … Speech & Language Delay & Disorders in Children Draft Research Plan Enhanced Risk Assessment for Cardiovascular … Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services  Health equity in cardiovascular … Evidence Gaps for Clinical Preventive Services  Recent evidence gaps related to cancer prevention and cardiovascular
  7. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/venous-thromboembolism-1.pdf
    March 01, 2020 - Aspirin is an antiplatelet, and while there are other antiplatelets used for other cardiovascular conditions … OR "Postoperative Complicati on*" OR "Perioperative Care Metho ds" OR Operation))) NOT ((MH "Cardiovascular … Diseases" OR Heart) OR (AB "Cardiovascular Disease*" OR Heart OR Cardiac))) ((((MH "Aspirin/Therapeutic … OR "Postoperative Complicati on*" OR "Perioperative Care Metho ds" OR Operation))) NOT ((MH "Cardiovascular … Diseases" OR Heart) OR (AB "Cardiovascular Disease*" OR Heart OR Cardiac))) Making Healthcare Safer
  8. hcup-us.ahrq.gov/reports/natstats/his96/table2.pdf
    February 11, 2011 - $10,450 $19,649 $35,666 10.9 3.6 64.0 51.3 respiratory system [42.] 7 Operations on the cardiovascular … 116,557 0.33 $31,743 $9,597 $18,143 $35,290 8.5 5.5 52.0 59.2 7.20 Other diagnostic cardiovascular … $7,346 $11,199 $17,466 5.4 0.9 55.3 61.5 procedures [62.] 7.21 Other non-OR therapeutic cardiovascular
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/worker-health_research-protocol.pdf
    May 26, 2015 - Health and safety outcomes (e.g., cardiovascular events or incidence of work- related injuries) Source … o KQ 2a: Health and safety outcomes: Mortality; incidence of injuries, cardiovascular disease or cancer
  10. effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - Additionally, patients with chronic hyperuricemia have an increased risk of cardiovascular disease, … However, better gout management could reduce hospitalizations and renal or cardiovascular complications
  11. effectivehealthcare.ahrq.gov/sites/default/files/ch_3-user-guide-to-ocer_130129.pdf
    September 21, 2012 - example of a prediction model is by Dorresteijn et al., who predicted the effect of rosuvastatin on cardiovascular … scores), as well as a prediction model developed using the trial data to calculate baseline risk of cardiovascular
  12. effectivehealthcare.ahrq.gov/sites/default/files/ch_10-user-guide-to-ocer_130129.pdf
    January 01, 2011 - Ray and colleagues39 reported effect modification by cardiovascular disease risk, derived and summarized … Adjustment for multiple cardiovascular risk factors using a summary risk score.
  13. effectivehealthcare.ahrq.gov/products/health-equity-preventive/research
  14. effectivehealthcare.ahrq.gov/products/type-2-diabetes-medications-update/research-protocol
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
    February 01, 2018 - Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes … Cardiovascular safety of non-steroidal anti- inflammatory drugs: network meta-analysis. … One considered frequently is major adverse cardiovascular events. … Statin Monotherapy: An Update Johns Hopkins University, 2014 Adults with moderate or high cardiovascular
  16. www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening
    May 18, 2021 - The USPSTF has a recommendation statement on aspirin use to prevent cardiovascular disease and colorectal … Recommendations The USPSTF has a recommendation statement on aspirin use for the primary prevention of cardiovascular … measure for the burden of screening), and resulting harms from colonoscopy (ie, gastrointestinal and cardiovascular … Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S.
  17. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-fullreport.pdf
    February 01, 2018 - example, a measure addressing childhood obesity may have implications for the subsequent development of cardiovascular … Severe sepsis includes sepsis plus one of the following clinical states: cardiovascular organ dysfunction … Septic shock is defined as sepsis and cardiovascular dysfunction (Goldstein, et al., 2005; Rivers, Ahrens … Shock occurs when the cardiovascular system is unable to provide energy resources (oxygen and glucose
  18. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-fullreport.pdf
    May 01, 2018 - example, a measure addressing childhood obesity may have implications for the subsequent development of cardiovascular … Severe sepsis includes sepsis plus one of the following clinical states: cardiovascular organ dysfunction … Septic shock is defined as sepsis and cardiovascular dysfunction (Goldstein, et al., 2005; Rivers, Ahrens … Shock occurs when the cardiovascular system is unable to provide energy resources (oxygen and glucose
  19. hcup-us.ahrq.gov/reports/methods/2007_04.pdf
    January 01, 2007 - System 1,066,769 11.0 220,143 3.0 Eye 767,584 7.9 134,544 1.9 Nervous System 678,902 7.0 147,181 2.0 Cardiovascular … CPT CCS Classification Available through the HCUP Central Distributor, 2004 SASD (continued) Cardiovascular … or spinal stimulator and injection into spinal canal 0.576 4 63 63: Other non-O.R. therapeutic cardiovascular … Other therapeutic procedures 1.400 7 62 62: Other diagnostic cardiovascular
  20. MAINTAIN AND EXPAND (pdf file)

    hcup-us.ahrq.gov/reports/methods/2011_01.pdf
    January 01, 2011 - Circulation: Cardiovascular Quality and Outcomes. 2008 Sep;1(1):29- 37. … Circulation: Cardiovascular Quality and Outcomes. 2009 Sep;2(5):407-13. … Elderly women have lower rates of stroke, cardiovascular events, and mortality after hospitalization … Circulation: Cardiovascular Quality and Outcomes. 2009 Nov;2(6):558-65.